Advertisement

Canadian Journal of Public Health

, Volume 92, Issue 1, pp 9–10 | Cite as

Controlling the Ischemic Heart Disease Epidemic: Strategies for the 21st Century

  • Sumit R. Majumdar
  • Ross T. Tsuyuki
  • Finlay A. McAlisterEmail author
Commentary

References

  1. 1.
    McKeown T. The Role of Medicine: Dream, Mirage, or Nemesis? 2nd edition. Princeton, NJ: Princeton University Press, 1979.Google Scholar
  2. 2.
    Chan B, Coyte P, Heick C. Economic impact of cardiovascular disease in Canada. Can J Cardiol 1996;12:1000–06.PubMedGoogle Scholar
  3. 3.
    Doll R. Preventive medicine: The objectives. In: The Value of Preventive Medicine, Proceedings from the CIBA Foundation Symposium. London: Pitman, 1985;3–21.Google Scholar
  4. 4.
    Woolf SH. The need for perspective in evidence-based medicine. JAMA 1999;282:2358–65.CrossRefGoogle Scholar
  5. 5.
    Smith CA, Pratt M. Cardiovascular disease epidemiology. In: Brownson RC, Remington PL, Davis JR (Eds.), Chronic Disease Epidemiology and Control. Washington: American Public Health Association, 1993;83–109.Google Scholar
  6. 6.
    Rose G. The Strategy of Preventive Medicine. New York: Oxford University Press, 1998.Google Scholar
  7. 7.
    Kottke TE, Puska P, Salonen JT, et al. Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol 1985;121:697–704.CrossRefGoogle Scholar
  8. 8.
    Russell LB. Is Prevention Better than Cure? Washington: Brookings Institution, 1986.Google Scholar
  9. 9.
    Nusselder WJ, van der Velden K, van Sonsbeek JLA, et al. The elimination of selected chronic diseases in a population: The compression and expansion of morbidity. Am J Public Health 1996;86:187–94.CrossRefGoogle Scholar
  10. 10.
    Sytkowski PA, Kannel WB, D’Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham Heart Study. N Engl J Med 1990;322:1635–41.CrossRefGoogle Scholar
  11. 11.
    Hunink MGM, Goldman L, Tosteson ANA, et al. The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. JAMA 1997;277:535–42.CrossRefGoogle Scholar
  12. 12.
    Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med 1998;129:406–11.CrossRefGoogle Scholar
  13. 13.
    Marmot MG, Kogevinas M, Elston MA. Socio-economic status and disease. Annu Rev Public Health 1987;8:111–35.CrossRefGoogle Scholar
  14. 14.
    Millar WJ, Wigle DT. Socioeconomic disparities in risk factors for cardiovascular disease. Can Med Assoc J 1986;134:127–32.Google Scholar
  15. 15.
    Kaplan NM. Evidence in favor of moderate dietary sodium restriction. Am J Hypertension 2000;13:8–13.CrossRefGoogle Scholar
  16. 16.
    Alderman MH, Cohen H, Madhaven S. Dietary sodium intake and mortality: NHANES 1. Lancet 1998;351:781–85.CrossRefGoogle Scholar
  17. 17.
    Caro J, Klittich W, McGuire A, et al. West of Scotland coronary prevention study: Economic benefit analysis of primary prevention with pravastatin. BMJ 1997;315:1577–82.CrossRefGoogle Scholar
  18. 18.
    Tosteson ANA, Weinstein MC, Hunink MGM, et al. Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. Circulation 1997;95:24–30.CrossRefGoogle Scholar
  19. 19.
    Manson JE, Tosteson H, Ridkeer PM, et al. The primary prevention of myocardial infarction. N Engl J Med 1992;326:1406–16.CrossRefGoogle Scholar
  20. 20.
    Wilkinson R. Unhealthy Societies: The Afflictions of Inequality. London: Routledge Press, 1997.Google Scholar
  21. 21.
    Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med 1986;15:254–73.CrossRefGoogle Scholar
  22. 22.
    Johannesson M, Jonsson B, Kjekshus J, et al. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. New Engl J Med 1997;336:332–36.CrossRefGoogle Scholar
  23. 23.
    McAlister FA, Taylor L, Teo KK, et al. The treatment and prevention of coronary heart disease in Canada: Do older patients receive efficacious therapies? J Am Geriatr Soc 1999;47:811–18.CrossRefGoogle Scholar
  24. 24.
    Cox JL. Optimizing disease management at a health care system level: The rationale and methods of the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study. Can J Cardiol 1999;15:787–96.PubMedGoogle Scholar

Copyright information

© The Canadian Public Health Association 2001

Authors and Affiliations

  • Sumit R. Majumdar
    • 1
    • 3
  • Ross T. Tsuyuki
    • 2
    • 3
  • Finlay A. McAlister
    • 1
    • 3
    Email author
  1. 1.Division of General Internal MedicineCanada
  2. 2.Division of CardiologyCanada
  3. 3.Epidemiology Coordinating and Research CentreCanada

Personalised recommendations